赛通姆治疗 CTMX
$2.19 +$0.05 (+2.34%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $2.19 0.00%
开盘$2.24
昨收$2.14
当日区间$2.12 – $2.27
成交量2.73M
市值$477.43M
市盈率（TTM）–
股息率–
财报
财报日平均波动±19.6%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+129.4%
最差反应-51.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±17.1% | +2.67% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±10.6% | -0.50% | 符合区间 |
| 2025/Q4 | 16 Mar 2026 | Pre Market | ±55.8% | +44.23% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±30.4% | -13.60% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±29.1% | +11.90% | 符合区间 |
| 2025/Q1 | 12 May 2025 | Pre Market | ±58.6% | +129.43% | 超出定价预期 |
| 2024/Q4 | 6 Mar 2025 | After Market | ±40.5% | +7.71% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±25.0% | +9.00% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±33.9% | +1.69% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±50.7% | -51.31% | 超出定价预期 |
| 2023/Q4 | 11 Mar 2024 | After Market | ±27.9% | -14.34% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±72.7% | -2.34% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±53.3% | -3.55% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±52.3% | +5.81% | 符合区间 |
| 2022/Q4 | 27 Mar 2023 | After Market | ±50.3% | -15.08% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±89.4% | +0.81% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.42M-92.4% YoY
营业利润-$23.78M-1,749.2% YoY
净利润-$20.67M-13,319.5% YoY
摊薄每股收益-$0.09
自由现金流-$18.07M-14.5% YoY
经营现金流-$18.07M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
营业利润率-476.2%
净利率-435.2%
净资产收益率-37.8%
资产收益率-28.6%
投入资本回报率-38.8%
流动比率9.36
负债/资产比率20.8%
现金及投资$330.28M
总负债$4.21M
净现金（净负债）$326.07M
暂无评论——快来第一个聊聊 CTMX。